1. Academic Validation
  2. HDAC8 regulates neural differentiation through embryoid body formation in P19 cells

HDAC8 regulates neural differentiation through embryoid body formation in P19 cells

  • Biochem Biophys Res Commun. 2018 Mar 25;498(1):45-51. doi: 10.1016/j.bbrc.2018.02.195.
Syouichi Katayama 1 Atsushi Morii 1 Juliet O Makanga 1 Takayoshi Suzuki 2 Naoki Miyata 3 Tetsuya Inazu 4
Affiliations

Affiliations

  • 1 Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan.
  • 2 Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Sakyo-ku, Kyoto 606-0823, Japan; CREST, Japan Science and Technology Agency (JST), Kawaguchi, Saitama 332-0012, Japan.
  • 3 Institute of Drug Discovery Science, Nagoya City University, Mizuho-ku, Nagoya 467-8603, Japan.
  • 4 Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan. Electronic address: [email protected].
Abstract

Histone acetylation and deacetylation correlate with diverse biological phenomena through gene transcription. Histone deacetylases (HDACs) regulate deacetylation of histones and other proteins. However, as a member of the HDAC family, HDAC8 function during neurodevelopment is currently unknown. Therefore, we investigated HDAC8 function during neurodevelopment by examining embryoid body (EB) formation in P19 cells. HDAC8-selective inhibitor (NCC-149) (HDAC8i)-treated cells showed smaller EBs than non-treated cells, as well as reduced expression levels of the neuronal marker, NeuN. Additionally, HDAC8i treatment led to inhibition of cellular proliferation by G2/M phase accumulation and downregulated cyclin A2 and cyclin B1 gene expression. Furthermore, two independent HDAC8 knockout cell lines were established by CRISPR-Cas9, which resulted in smaller EBs, similar to HDAC8i-treated cells. These results suggest that HDAC8 regulates neural differentiation by exerting control of EB formation.

Keywords

CRISPR-Cas9; Cell cycle; HDAC8; HDAC8-Selective inhibitor; NCC-149; Neurodevelopment.

Figures
Products